Sweden· SE-20170726000067
Symkevi 100 mg/150 mg Filmdragerad tablett
A medicinal product containing tezacaftor + ivacaftor, registered in Sweden by Vertex Pharmaceuticals Ireland Ltd.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tezacaftor + Ivacaftor
- Manufacturer
- Vertex Pharmaceuticals Ireland Ltd
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20170726000067
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tezacaftor + ivacaftor in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandSymkeviVERTEX PHARMACEUTICALS (Ireland) Limited
- SwitzerlandSymdeko 100 mg / 150 mg und 150 mg, FilmtablettenVertex Pharmaceuticals (CH) GmbH
- CzechiaSYMKEVIVertex Pharmaceuticals (Ireland) Limited, Dublin
- SpainSYMKEVI 100 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULAVertex Pharmaceuticals (Ireland) Limited
- FranceSYMKEVI 100 mg/150 mg, comprimé pelliculéVERTEX PHARMACEUTICALS (EUROPE) ROYAUME-UNI)
- United KingdomSymkevi 100mg/150mg tabletsVertex Pharmaceuticals (Europe) Ltd
- IrelandSymkevi 100 mg/150 mg Film-coated tabletVertex Pharmaceuticals (Ireland) Limited
- IcelandSymkeviVertex Pharmaceuticals (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Symkevi
- Liechtenstein · Symkevi
- Norway · Symkevi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3f1af076-e707-4815-858e-4b083f696ba6 GET /v1/drugs/3f1af076-e707-4815-858e-4b083f696ba6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20170726000067",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20170726000067",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/symkevi"
}See everything about tezacaftor + ivacaftor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.